These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2612238)

  • 1. Therapy of lower respiratory tract infections: a comparison of ceftriaxone and cefotaxime.
    Barradas P; Zamith M; Videira W; Cardosa T; Marques RA; Avila R
    Chemotherapy; 1989; 35 Suppl 2():33-40. PubMed ID: 2612238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection].
    Gao B; Hu J; Deng W
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):528-31. PubMed ID: 11360502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of lower respiratory tract infections with ceftriaxone and cefotaxime. A comparative study.
    Abbate GF; Alagia I; Giaquinto E; Leonessa V; Savioli L; Altucci P; Caputi M; Guarino C; Micillo E; Catena E
    Respiration; 1986; 49(3):222-30. PubMed ID: 3515468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ceftriaxone in the therapy of infections of the lower respiratory tract: comparison with cefotaxime].
    Lanni N; Scaglione B
    Minerva Med; 1986 Mar; 77(9-10):317-9. PubMed ID: 3485265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative clinical evaluation of ceftriaxone in treating lower respiratory tract infections.
    Abbate GF; Alagia I; Giaquinto E; Leonessa V; Caputi M; Guarino C; Micillo E; Catena E; Altucci P
    Chemioterapia; 1986 Feb; 5(1):26-32. PubMed ID: 3955779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy and adverse effect profile of cefotaxime and ceftriaxone in ICU patients with susceptible infections.
    Thomas P; Daly S; Misan G; Steele T
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):89-97. PubMed ID: 1730190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study.
    Mandell LA; Bergeron MG; Ronald AR; Vega C; Harding G; Saginur R; Feld R; Duperval R; Landis SJ; Miedzinski LJ
    J Infect Dis; 1989 Sep; 160(3):433-41. PubMed ID: 2668427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A well-controlled comparative study on ceftriaxone with cefotaxime in respiratory tract infections].
    Kobayashi H; Takamura K; Oshitani H; Nihei T; Saito A; Tomizawa M; Nakayama I; Ishikawa K; Abe M; Kuroda Y
    Kansenshogaku Zasshi; 1986 Feb; 60(2):102-24. PubMed ID: 3090162
    [No Abstract]   [Full Text] [Related]  

  • 9. Ceftriaxone therapy of serious bacterial infections.
    Eron LJ; Park CH; Goldenberg RI; Poretz DM
    J Antimicrob Chemother; 1983 Jul; 12(1):65-78. PubMed ID: 6311783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, open comparative study of parenteral cefotaxime and ceftriaxone in the treatment of nosocomial lower respiratory tract infections.
    Garber GE; Auger P; Chan RM; Conly JM; Shafran SD; Gerson M
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):85-8. PubMed ID: 1730189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of ceftriaxone with cefotaxime in serious chest infections.
    Reeves JH; Russell GM; Cade JF; McDonald M
    Chest; 1989 Dec; 96(6):1292-7. PubMed ID: 2684552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone monotherapy for severe bacteremic infections. Spanish Ceftriaxone Study Group.
    Soriano E; Gatell JM; Aguado JM; Aguirre JM; Arazo P; Arribas JL; Barros C; Cartón JA; Gurgui M; Jiménez E
    Chemotherapy; 1989; 35 Suppl 2():27-32. PubMed ID: 2612237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the relationship between pharmacokinetics and antibacterial activity: comparison between ceftriaxone and cefotaxime within the respiratory tract.
    Fraschini F; Scaglione F
    Chemotherapy; 1989; 35(2):77-82. PubMed ID: 2758870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of ceftriaxone.
    File TM; Tan JS; Salstrom SJ
    Clin Ther; 1984; 6(5):653-61. PubMed ID: 6090021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of intravenous ceftriaxone followed by oral cefixime versus ceftriaxone alone in the treatment of severe upper urinary tract infections].
    Regnier B
    Presse Med; 1989 Oct; 18(32):1617-21. PubMed ID: 2530546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftriaxone versus cefotaxime in the treatment of septicemia in adults.
    Ferencz A; Prinz G; Szalka A; Ban E
    Chemotherapy; 1989; 35 Suppl 2():5-9. PubMed ID: 2612239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
    Jauregui L; Minns P; Hageage G
    J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftriaxone compared with cefotaxime for serious bacterial infections.
    Smith CR; Petty BG; Hendrix CW; Kernan WN; Garver PL; Fox K; Beamer A; Carbone K; Threlkeld M; Lietman PS
    J Infect Dis; 1989 Sep; 160(3):442-7. PubMed ID: 2668428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation and perspectives of a new cephalosporin: ceftriaxone].
    Auvergnat JC; Armengaud M
    Rev Med Interne; 1985 Mar; 6(2):187-92. PubMed ID: 3839091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefotaxime twice daily versus ceftriaxone once daily. A randomized controlled study in patients with serious infections.
    Simmons BP; Gelfand MS; Grogan J; Craft B
    Diagn Microbiol Infect Dis; 1995; 22(1-2):155-7. PubMed ID: 7587031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.